Clinical Trial Update: Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pembrolizumab to platinum-based chemotherapy in metastatic non-small cell lung cancer has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Non-Small Cell Lung Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2017-07-07